Message Font: Serif | Sans-Serif
 
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev Thread | Prev | Next | Next Thread
Author: qualitystocks Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 8  
Subject: Cytori Therapeutics, Inc. (CYTX) Date: 4/14/2009 2:37 PM
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Recommendations: 0
Cytori Therapeutics, Inc. (NASDAQ: CYTX) has developed technology designed to assist the physician in reconstructive and aesthetic surgery procedures. The company’s mission is to improve the quality and length of life by providing innovative regenerative therapies to patients. Their key technology is the Celution® 700 system that prepares an autologous tissue graft for delivery back to the patient in the same surgical procedure.

Although Celution® is currently unavailable in the U.S., the technology is under review by the US Food and Drug Administration (FDA) and commercially available in many countries in Europe and Asia. Cytori is actively pursuing the expansion of their distributor network to target distributor partnerships in South America as well as other regions. The company is also investigating the possibility of using their technology for indications beyond reconstructive and aesthetic surgery.

The Celution® 900/MB System is the foundation of the company’s StemSource™ Cell Bank. This cell bank enables hospitals in Japan to offer patients the service of cryopreserving their adipose-derived adult stem and regenerative cells (ADRCs) to potentially save their lives in the event they are required for future medical treatment. Research and development has shown that cord blood stem cells have tremendous future value for treating blood disorders and genetic diseases.

In addition, Cytori is exploring the possibility of using adipose-derived stem and regenerative cells (ADRCs), processed with their Celution® 800/CV System, to treat heart disease. The company recognizes the tremendous need for new therapies to repair heart muscle damaged from heart attacks or chronic heart conditions. Adipose tissue-derived stem and regenerative cells may become an effective treatment option for such conditions.
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev Thread | Prev | Next | Next Thread

Announcements

Post of the Day:
Berkshire Hathaway

Starting a Small Business
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement